Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$4.13
+2.2%
$4.30
$2.90
$6.18
$521.74M1.181.03 million shs2.02 million shs
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
$11.63
-2.4%
$9.40
$1.18
$13.84
$479.73M-0.821.34 million shs1.24 million shs
Quanterix Corporation stock logo
QTRX
Quanterix
$3.09
-1.3%
$3.17
$2.39
$8.77
$147.44M1.141.18 million shs817,953 shs
SiBone stock logo
SIBN
SiBone
$15.53
+3.7%
$13.78
$11.48
$21.89
$663.91M0.7727,358 shs328,663 shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-1.22%-4.72%-12.36%-4.49%+17.44%
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
+4.93%+9.87%+62.70%+49.06%+715.75%
Quanterix Corporation stock logo
QTRX
Quanterix
-5.15%-10.57%+10.60%-37.65%-41.71%
SiBone stock logo
SIBN
SiBone
-0.99%+7.93%+22.00%+8.32%-20.79%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$4.13
+2.2%
$4.30
$2.90
$6.18
$521.74M1.181.03 million shs2.02 million shs
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
$11.63
-2.4%
$9.40
$1.18
$13.84
$479.73M-0.821.34 million shs1.24 million shs
Quanterix Corporation stock logo
QTRX
Quanterix
$3.09
-1.3%
$3.17
$2.39
$8.77
$147.44M1.141.18 million shs817,953 shs
SiBone stock logo
SIBN
SiBone
$15.53
+3.7%
$13.78
$11.48
$21.89
$663.91M0.7727,358 shs328,663 shs
Beginner's Guide To Retirement Stocks Cover

Click the link to see MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-1.22%-4.72%-12.36%-4.49%+17.44%
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
+4.93%+9.87%+62.70%+49.06%+715.75%
Quanterix Corporation stock logo
QTRX
Quanterix
-5.15%-10.57%+10.60%-37.65%-41.71%
SiBone stock logo
SIBN
SiBone
-0.99%+7.93%+22.00%+8.32%-20.79%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
2.33
Hold$5.6937.71% Upside
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
1.00
SellN/AN/A
Quanterix Corporation stock logo
QTRX
Quanterix
1.67
Reduce$4.0029.45% Upside
SiBone stock logo
SIBN
SiBone
2.71
Moderate Buy$23.0048.10% Upside

Current Analyst Ratings Breakdown

Latest QTRX, SIBN, CTKB, and OPTX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/13/2026
Quanterix Corporation stock logo
QTRX
Quanterix
DowngradeSell (D-)Sell (E+)
5/13/2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Lower Price TargetOverweight$5.50 ➝ $4.75
5/12/2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Lower Price TargetEqual Weight$6.00 ➝ $5.50
5/12/2026
SiBone stock logo
SIBN
SiBone
Lower Price TargetBuy$22.00 ➝ $18.00
5/12/2026
SiBone stock logo
SIBN
SiBone
Reiterated RatingBuy$20.00 ➝ $18.00
5/7/2026
Quanterix Corporation stock logo
QTRX
Quanterix
Lower Price TargetHold$7.00 ➝ $4.00
4/21/2026
Quanterix Corporation stock logo
QTRX
Quanterix
Reiterated RatingSell (D-)
4/20/2026
Quanterix Corporation stock logo
QTRX
Quanterix
Lower Price TargetHold$8.00 ➝ $4.00
4/15/2026
SiBone stock logo
SIBN
SiBone
Lower Price TargetBuy$24.00 ➝ $20.00
3/27/2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
Reiterated RatingSell (D-)
(Data available from 6/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
$201.49M2.65N/AN/A$2.67 per share1.55
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
$28.08M16.68$0.02 per share525.98$0.26 per share44.73
Quanterix Corporation stock logo
QTRX
Quanterix
$138.90M1.05N/AN/A$6.33 per share0.49
SiBone stock logo
SIBN
SiBone
$200.93M3.43N/AN/A$4.09 per share3.80
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$66.54M-$0.57N/A413.00N/A-36.25%-10.07%-7.56%8/5/2026 (Estimated)
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
-$1.79M-$0.08N/AN/AN/A-10.95%-30.86%-12.35%N/A
Quanterix Corporation stock logo
QTRX
Quanterix
-$107.15M-$2.36N/AN/AN/A-71.86%-23.92%-17.66%8/6/2026 (Estimated)
SiBone stock logo
SIBN
SiBone
-$18.90M-$0.39N/AN/AN/A-8.10%-9.56%-7.06%8/3/2026 (Estimated)

Latest QTRX, SIBN, CTKB, and OPTX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2026Q1 2026
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
N/A-$0.02N/A-$0.02N/A$6.51 million
5/11/2026Q1 2026
SiBone stock logo
SIBN
SiBone
-$0.17-$0.10+$0.07-$0.10$51.16 million$52.59 million
5/7/2026Q1 2026
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
-$0.08-$0.15-$0.07-$0.15$44.23 million$44.14 million
5/6/2026Q1 2026
Quanterix Corporation stock logo
QTRX
Quanterix
-$0.5133-$0.39+$0.1233-$0.37$36.84 million$35.90 million
3/31/2026Q4 2025
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
N/A-$0.01N/A-$0.01N/A$7.51 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/AN/AN/AN/AN/A
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
N/AN/AN/AN/AN/A
Quanterix Corporation stock logo
QTRX
Quanterix
N/AN/AN/AN/AN/A
SiBone stock logo
SIBN
SiBone
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
N/A
4.69
4.07
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
0.41
1.28
0.59
Quanterix Corporation stock logo
QTRX
Quanterix
N/A
3.72
2.70
SiBone stock logo
SIBN
SiBone
0.20
9.99
8.34

Institutional Ownership

CompanyInstitutional Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
69.46%
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
N/A
Quanterix Corporation stock logo
QTRX
Quanterix
86.48%
SiBone stock logo
SIBN
SiBone
98.11%

Insider Ownership

CompanyInsider Ownership
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
10.36%
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
0.83%
Quanterix Corporation stock logo
QTRX
Quanterix
1.50%
SiBone stock logo
SIBN
SiBone
3.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Cytek Biosciences, Inc. stock logo
CTKB
Cytek Biosciences
500129.14 million115.76 millionOptionable
Syntec Optics Holdings, Inc. stock logo
OPTX
Syntec Optics
340.28 million39.95 millionN/A
Quanterix Corporation stock logo
QTRX
Quanterix
46047.11 million46.40 millionOptionable
SiBone stock logo
SIBN
SiBone
35044.35 million42.62 millionOptionable

Recent News About These Companies

Jeffrey Dunn Sells 3,575 Shares of SiBone (NASDAQ:SIBN) Stock
Gazprom Neft says Q1 profit down 3.5% y/y
UBS Group AG Raises Stake in SiBone $SIBN
SiBone (NASDAQ:SIBN) SVP Sells 3,726 Shares
SiBone Q1 Earnings Call Highlights

New MarketBeat Followers Over Time

Media Sentiment Over Time

Cytek Biosciences stock logo

Cytek Biosciences NASDAQ:CTKB

$4.13 +0.09 (+2.23%)
Closing price 04:00 PM Eastern
Extended Trading
$4.15 +0.02 (+0.48%)
As of 07:19 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells; and aurora cell sorter system that leverages full spectrum profiling technology to further broaden potential applications across cell analysis; aurora CS systems; amnis imagestream imaging flow cytometers; guava muse cell analyzers; guava easycyte flow cytometers; and orion reagent cocktail preparation systems. The company also provides reagents and kits, including cFluor reagents that are fluorochrome conjugated antibodies used to identify cells of interest for analysis on its instruments, as well as 25-color immunoprofiling assay that provides turnkey solutions for identifying major human immune subpopulations for TBNK cells, monocytes, dendritic cells, and basophils. In addition, it offers automated micro-sampling system and automated sample loader system, an automated loaders to integrate seamlessly into the aurora and northern lights systems; SpectroFlo software that provides intuitive workflow from quality control to data analysis for aurora and northern lights systems; and customer support tools. The company serves pharmaceutical and biopharma companies, academic research centers, and clinical research organizations. It distributes its products through direct sales force and support organizations in North America, Europe, China, and the Asia-Pacific regions; and through distributors or sales agents in European, Latin American, and the Middle Eastern countries. The company was formerly known as Cytoville, Inc. and changed its name to Cytek Biosciences, Inc. in August 2015. Cytek Biosciences, Inc. was founded in 1992 and is headquartered in Fremont, California.

Syntec Optics stock logo

Syntec Optics NASDAQ:OPTX

$11.63 -0.28 (-2.35%)
Closing price 04:00 PM Eastern
Extended Trading
$11.87 +0.24 (+2.07%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Syntec Optics Holdings, Inc. manufactures and supplies integrated optics for biomedical, defense and military, consumer, and other applications. It offers camera modules; tool design, design for manufacturing, optical and opto-mechanical design, and moldflow analysis; SPDT optics, such as freedom optics, microlens arrays, spheres and aspheres, diffractives, SPDT materials, and optical tooling; replicative molding, that includes polymer and glass molding, and molded production materials; thin film coating and coating curve materials; and precision machining and precision machining materials. The company also provides clean room assembly, such as opto mechanical, opto electronic, and integrated photonics; infrared optics, microlens arrays, software development, and optical metrology, and catalog optics services. In addition, it offers driverless cars, integrated photonics, robotics, sensors, VR and AR, machine vision, facial imagining, heads up display, finger print scanners, and laser scanners technology for consumers; night vision goggles, missile laser guides, biometrics, infrared and thermal imaging, ordnance optics, head mounted displays, 2D and 3D scanners, humvee lighting , laser targeting, protective domes and windows, and lidar technologies for defense and miliary; and medical diagnostic, microfluidics, surgical components and systems, and medical sensing technology for medical sectors. The company was founded in 1981 and is based in Rochester, New York.

Quanterix stock logo

Quanterix NASDAQ:QTRX

$3.09 -0.04 (-1.28%)
Closing price 04:00 PM Eastern
Extended Trading
$3.05 -0.04 (-1.29%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

SiBone stock logo

SiBone NASDAQ:SIBN

$15.53 +0.56 (+3.74%)
Closing price 04:00 PM Eastern
Extended Trading
$15.54 +0.01 (+0.06%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

SI-BONE, Inc., a medical device company, that operate to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma; and implantable bone products. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ, a set of 3D-printed threaded implants designed to treat pelvic trauma; and iFuse Bedrock Granite implant provides sacroiliac fusion and sacropelvic fixation as a foundational element for segmental spinal fusion. It markets its products primarily with a direct sales force, as well as through agents and resellers. SI-BONE, Inc. was incorporated in 2008 and is headquartered in Santa Clara, California.